Jason Glanz to Opioid-Related Disorders
This is a "connection" page, showing publications Jason Glanz has written about Opioid-Related Disorders.
Connection Strength
2.632
-
Association Between Opioid Dose Reduction Rates and Overdose Among Patients Prescribed Long-Term Opioid Therapy. Subst Abus. 2023 07; 44(3):209-219.
Score: 0.731
-
Opioid Dose Trajectories and Associations With Mortality, Opioid Use Disorder, Continued Opioid Therapy, and Health Plan Disenrollment. JAMA Netw Open. 2022 10 03; 5(10):e2234671.
Score: 0.685
-
Modifying and Evaluating the Opioid Overdose Knowledge Scale for Prescription Opioids: A Pilot Study of the Rx-OOKS. Pain Med. 2020 10 01; 21(10):2244-2252.
Score: 0.596
-
Pharmaceutical Opioids in the Home and Youth: Implications for Adult Medical Practice. Subst Abus. 2015; 36(2):141-3.
Score: 0.403
-
Potential Risk Window for Opioid Overdose Related to Treatment with Extended-Release Injectable Naltrexone. Drug Saf. 2018 10; 41(10):979-980.
Score: 0.130
-
National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009. Drug Alcohol Depend. 2013 Aug 01; 131(3):263-70.
Score: 0.087